| Stage | HLNE | % of rev | BX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $204M | 100.00% | $5.0B | 100.00% | BX ×24.67 |
| Gross profit | $127M | 62.11% | $5.0B | 100.00% | BX +37.9pp |
| Operating income | $86M | 42.23% | $2.7B | 52.90% | BX +10.7pp |
| Pre-tax income | $179M | 87.37% | $2.8B | 55.68% | HLNE +31.7pp |
| Net income | $149M | 72.85% | $2.4B | 46.71% | HLNE +26.1pp |
| Stage | HLNE | BX | Gap · A − B |
|---|---|---|---|
| Revenue | $204M100.00% | $5.0B100.00% | BX ×24.67 |
| Gross profit | 62.11%$127M | 100.00%$5.0B | BX +37.9pp |
| Operating income | 42.23%$86M | 52.90%$2.7B | BX +10.7pp |
| Pre-tax income | 87.37%$179M | 55.68%$2.8B | HLNE +31.7pp |
| Net income |
| 72.85%$149M |
| 46.71%$2.4B |
| HLNE +26.1pp |
No shared counterparties.